Biogen Inc. buy UBS Group AG
Start price
22.04.26
/
50%
€162.56
Target price
22.04.27
€191.59
Performance (%)
2.17%
Price
09:04
€166.08
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 2.17%. This prediction currently runs until 22.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 1.101% | 1.101% |
| iShares Core DAX® | -2.195% | 0.670% |
| iShares Nasdaq 100 | -2.629% | 2.992% |
| iShares Nikkei 225® | -2.021% | 3.141% |
| iShares S&P 500 | -1.670% | 2.405% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was upgraded by UBS Group AG from "neutral" to "buy". They now have a $225.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat